World Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
J Med Virol. 2012 Apr;84(4):691-6. doi: 10.1002/jmv.23228.
The milestone in polio eradication program is to protect effectively children aged 0-5 years against the three serotypes of poliovirus. It became necessary to measure the level of neutralizing antibodies to the three poliovirus types in an endemic State in Nigeria. Neutralizing antibodies to the poliovirus types among children aged 0-5 years was estimated using micro neutralization assay. Of 129 children, 99 (76.8%), 95 (73.6%), and 95 (73.6%) had neutralizing antibodies with the geometric mean titer of 42.7, 31.3, and 33.2 for the poliovirus type 1, 2, and 3, respectively. Fifty-three percent of the children were protected against the three types of poliovirus. Combination of poliovirus types 1 and 2, 1 and 3, and 2 and 3 were neutralized by 62.8, 58.9, and 61.2% of the children studied, respectively. Only poliovirus type 1 induced antibody titres ≥1:1,024. The number of children with neutralizing antibodies after receiving three doses was significantly higher than those who received one or two doses of oral polio vaccine (P ≤ 0.05). However, those who received more than three doses of oral polio vaccine showed no significant difference in their antibody response. The existence of immunity gap poses a risk of re-emergence of the paralytic poliovirus. The existence of unimmunized and unprotected children along with high birth rate could impede the success of polio vaccination in Nigeria. Elimination of non-compliance to polio vaccine, promotion of health education and documented evidence of vaccination of each child with the parents may facilitate the success of polio eradication program in Nigeria.
在消灭脊灰炎计划中,一个重要的里程碑就是要有效地保护 0-5 岁的儿童免受三种脊灰炎病毒的侵害。在尼日利亚这个流行国家,有必要衡量儿童对三种脊灰炎病毒的中和抗体水平。通过微量中和试验,估计了 0-5 岁儿童的脊灰炎病毒中和抗体。在 129 名儿童中,99 名(76.8%)、95 名(73.6%)和 95 名(73.6%)儿童对脊灰炎病毒 1 型、2 型和 3 型的中和抗体几何平均滴度分别为 42.7、31.3 和 33.2。53%的儿童对三种脊灰炎病毒有保护作用。研究中,62.8%、58.9%和 61.2%的儿童中和了脊灰炎病毒 1 型和 2 型、1 型和 3 型以及 2 型和 3 型的组合。只有脊灰炎病毒 1 型诱导的抗体滴度≥1:1,024。接受三剂口服脊灰炎疫苗的儿童的中和抗体数量明显高于接受一剂或两剂疫苗的儿童(P≤0.05)。然而,接受三剂以上口服脊灰炎疫苗的儿童的抗体反应没有显著差异。免疫空白的存在,增加了瘫痪性脊灰炎病毒再次出现的风险。未免疫和未受保护儿童的存在,以及高出生率,可能会阻碍尼日利亚脊灰炎疫苗接种的成功。消除对脊灰炎疫苗的不遵守、推广健康教育和为每个儿童提供与父母的疫苗接种记录,可能有助于尼日利亚脊灰炎消除计划的成功。